Middle East & Africa Implantable Medical Devices Market Forecast to 2030 - Regional Analysis - By Implant Type, Product Type, Material Type, Application, and End Users

The Middle East & Africa implantable medical devices market is expected to grow from US$3.24 billion in 2022 to US$5.34 billion by 2030. It is estimated to grow at a CAGR of 6.4% from 2022 to 2030.

Growing Areas of Application of Implantable Medical Devices Fuel the Middle East & Africa Implantable Medical Devices Market

Medical implants are devices positioned inside the body. The implantable medical devices are used to replace missing body parts, deliver medication, monitor body functions, or support organs and tissues. Implantable medical devices are important to healthcare as they completely increase patients' safety and quality of life. Many implantable medical devices monitor blood pressure and irregular heartbeat, which help alert medical specialists for signs of criticality and also direct individuals toward appropriate care. A few widely used implants are pacemakers, defibrillators, cardiovascular stents, neural prosthetics, and drug delivery systems. According to an article titled "Bone Health 2022," osteoporosis causes over 8.9 million fractures every year, leading to an osteoporotic fracture every 3 seconds worldwide. Patients suffering bone fractures in different body parts require implants that will enable a function similar to that of the natural bone they are replacing. Joint diseases (rheumatoid arthritis and osteoarthritis) also require surgical intervention with hip and knee replacement implants. Biomaterial implants are used to fix fractures or replace parts of the body. For most of these implant cases, either metal or polymer biomaterials are preferred for their similar functional capacity to the original bone material. Moreover, according to the WHO, nervous disorders contribute to ~6.3% of the global disease burden. Also, according to the same source, nervous disorders are one of the leading causes of death worldwide. They cause 13.2% of deaths in developed countries and 16.8% in low- and middle-income countries. High mortality and disease burden necessitate the clinical urgency for integrating long-term solutions. Furthermore, growing awareness regarding the tremendous burden of neurological disorders has increased the demand for neurostimulators. As per World Cancer Research Fund International, breast cancer is the most common cancer in women in developed and developing countries. In 2020, there were more than 2.2 million new breast cancer cases in women. Breast implants are medical devices that are implanted under the breast tissue or chest muscle to boost breast size (augmentation) or replace breast tissue removed due to cancer. Therefore, the rising application of medical implant devices in breast cancer, neurological disorders, and osteoporosis drives the growth of the implantable medical device market.

Middle East & Africa Implantable Medical Devices Market Overview

The Middle East & Africa implantable medical devices market is segmented into Saudi Arabia, the UAE, South Africa, and the Rest of Middle East & Africa. The Middle East & Africa implantable medical devices market is expected to witness significant growth during the forecast period due to the prevalence of CVDs and investments to elevate healthcare in the region.

Middle East & Africa Implantable Medical Devices Market Segmentation

The Middle East & Africa implantable medical devices market is segmented into implant type, product type, material type, application, end users, and country.

Based on implant type, the Middle East & Africa implantable medical devices market is bifurcated into active implant & passive implant. The passive implant segment held a larger share of the Middle East & Africa implantable medical devices market in 2022.

Based on product type, the Middle East & Africa implantable medical devices market is bifurcated into diagnostic & treatment. The treatment segment held a larger share of the Middle East & Africa implantable medical devices market in 2022.

Based on material type, the Middle East & Africa implantable medical devices market is segmented into metallic, ceramic, and polymers. The metallic segment held the largest share of the Middle East & Africa implantable medical devices market in 2022.

Based on application, the Middle East & Africa implantable medical devices market is segmented into dental implants, orthopedic implants, cardiovascular implants, breast implants, brain implants, and others. The orthopedic implants segment held the largest share of the Middle East & Africa implantable medical devices market in 2022.

Based on end users, the Middle East & Africa implantable medical devices market is segmented into hospitals, specialty clinics, ASCs, and others. The hospitals segment held the largest share of the Middle East & Africa implantable medical devices market in 2022.

Based on country, the Middle East & Africa implantable medical devices market is segmented into Saudi Arabia, South Africa, the UAE, and the Rest of Middle East & Africa. Saudi Arabia dominated the Middle East & Africa implantable medical devices market in 2022.

Abbott Laboratories, Boston Scientific Corp, Dentsply Sirona Inc, Johnson & Johnson, Medtronic Plc, Institut Straumann AG, Smith & Nephew Plc, LivaNova Plc, MED-EL Elektromedizin Gerate Gesellschaft mbH are some of the leading companies operating in the Middle East & Africa implantable medical devices market.